Skip to main content

Advanced Search

Advanced Search

Current Filters

Filter your query

Publication Types

Other

to

Grant

/

Increasing the Efficiency of the U.S. Drug Market to Benefit Patients

Grant Details

Grantee Organization
The Brigham and Women's Hospital, Inc.

Principal Investigator
Aaron Kesselheim, M.D., J.D. M.P.H.

Term
5/1/22 - 4/30/23

Award Amount
$365,143

Approval Year

Related Program
Controlling Health Care Costs

Topics
Health System Performance and Costs

Grant Details

Grantee Organization
The Brigham and Women's Hospital, Inc.

Principal Investigator
Aaron Kesselheim, M.D., J.D. M.P.H.

Term
5/1/22 - 4/30/23

Award Amount
$365,143

Approval Year

Related Program
Controlling Health Care Costs

Topics
Health System Performance and Costs

The project team will identify areas ripe for patent reform by examining tertiary patents on devices used to administer drugs. The researchers will evaluate the externalities associated with extensions of patent terms, assess the criteria used to review patent applications, and analyze the effectiveness of the Patent Trial and Appeals Board at weeding out improperly granted patents. In addition, the team will identify ways to incentivize development of high-value drugs by examining the role various funding sources — public, nonprofit, and private — played in the development of drugs deemed innovative by international health technology assessment organizations. Lastly, the team will evaluate and quickly respond to proposed changes to the FDA regulatory process — including the accelerated approval pathway — that may be considered when the Prescription Drug User Fee Act comes up for renewal in fall 2022.

Related Grants

Where High U.S. Health Care Prices Are Going

Helping States Adopt Cost Containment Policies

Prescription Drug Education and Explainers